Streetbeat News

Stock Prices

MGIC

Magic Software (NASDAQ:MGIC) reported Q3 adjusted EPS of $0.21, missing the $0.27 estimate, and sales of $129.48M, below the $146.40M estimate. This reflects a 25% decrease in earnings and a 10.06% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:49 pm

COIN

ORCL

QCOM

SO

Insiders at Oracle, Qualcomm, Southern Company, and Coinbase Global have recently sold shares. Insider sales can indicate various sentiments about the stock's value or company prospects. Notably, Kathryn Haun of Coinbase sold shares at $99 each, George N. Conrades of Oracle at $112.87, Stephen E Kuczynski of Southern at $68.39, and James J Cathey of Qualcomm at $124. These transactions occurred amidst various company-specific news such as earnings reports and analyst upgrades.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:47 pm

EBIX

Ebix, Inc. (NASDAQ:EBIX) reported a Q3 adjusted EPS of $(0.11), significantly missing the analyst consensus estimate of $0.07. This represents a sharp decline from the $0.70 per share earned in the same quarter of the previous year. Quarterly sales were also below expectations at $119.23M, missing the $124.28M estimate and showing a 53.77% decrease from the previous year's same quarter sales of $257.90M.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:46 pm

NETI

Eneti Inc. (NYSE:NETI) reported Q3 earnings with an EPS of $0.49, surpassing the estimate of $0.27 by 81.48%. However, revenue decreased by $16.00 million compared to the same period last year. In the previous quarter, Eneti's EPS beat estimates by $0.02, leading to a 1.75% share price increase the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:45 pm

GDHG

Golden Heaven Group Holdings (GDHG) shares continue to trade lower following a short report from Hindenburg Research that caused a decline in stock price on Monday.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:44 pm

ANSS

B of A Securities analyst Andrew Obin has downgraded Ansys (NASDAQ:ANSS) from Buy to Underperform and reduced the price target from $356 to $295.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 12:43 pm

INVO

INVO Bioscience, Inc. (NASDAQ:INVO) shares increased by over 31% in pre-market trading due to a narrower Q3 loss and a 314% surge in quarterly sales. Other stocks experienced pre-market movements, with notable gainers including TCRT, AIRE, HRYU, THRX, RDHL, ABSI, PXMD, ADN, OMIC, and losers such as SKIN, HROW, AUVI, AKLI, HTCR, PRSO, FSR, TCON, TENX, XAIR.

Portfolio Pulse from Lisa Levin

November 14, 2023 | 12:41 pm

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q3 earnings with an EPS of $0.09, surpassing the estimate of $0.05 by 80%. Revenue increased by $12.50 million compared to the same period last year. Despite beating EPS estimates last quarter, CLBT's share price dropped by 0.5% the following day.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:40 pm

PTN

Palatin Technologies (AMEX:PTN) reported Q1 earnings with an EPS of $-0.48, missing estimates by 17.07% compared to the expected $-0.41. However, revenue increased by $1.24 million from the same period last year. Despite missing EPS estimates last quarter, PTN's share price increased by 0.67% the following day. Historical earnings performance shows a pattern of not meeting EPS estimates.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:40 pm

BKKT

Bakkt Holdings (NYSE:BKKT) reported Q3 earnings with an EPS of $-0.19, missing estimates by 11.76% against the expected $-0.17. However, revenue saw a significant increase from the same period last year, up by $191.90 million. In the previous quarter, BKKT beat EPS estimates by $0.01, leading to a 3.65% rise in share price the following day. The company's past earnings performance shows variability in EPS actuals compared to estimates, with a notable loss in Q4 2022.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 12:40 pm